Assessing the risk of impaired glucose metabolism in overweight adolescents in a clinical setting

Journal of Nutrition, Health and Aging

Volumn 12, Issue 10 SUPPL., 2008, Pages

  Velasquez Mieyer, Pedro A ^a,b   Cowan, P A ^a   Niera, C P ^a   Tylavsky, F ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b LeBonheur Children s Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 58049083208     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. World Health Organization. Fact sheet: Obesity and overweight. World Health Organization, 2006.
2. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002;288:1728-32.
3. Troiano RP, Flegal KM, Kuczmarski RJ, Campbell SM, Johnson CL. Overweight prevalence and trends for children and adolescents. The National Health and Nutrition Examination Surveys, 1963 to 1991. Archives of Pediatrics and Adolescent Medicine 1995;149:1085-91.
4. Commission of the European Communities. Green Paper: Promoting healthy diets and physical activity: A Europena dimension for the prevention of overweight, obesity and chronic diseases. Brussels, 2005.
5. Cossrow N, Falkner B. Race/ethnic issues in obesity and obesity-related comorbidities. J Clin Endocrinol Metab 2004;89:2590-4.
6. Serdula MK, Ivery D, Coates RJ, Freedman DS, Williamson DF, Byers T. Do obese children become obese adults? A review of the literature. Preventive Medicine 1993;22:167-77.
7. Goo SS, Wu W, Chumlea WC, Roche AF. Predicting overweight and obesity in adulthood from body mass index values in childhood and adolescence. American Journal of Clinical Nutrition 2002;76:653-8.
8. DiPietro L, Mossberg HO, Stunkard AJ. A 40-year history of overweight children in Stockholm: life-time overweight, morbidity, and mortality. International Journal of Obesity and Related Metabolic Disorders 1994;18:585-90.
9. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. New England Journal of Medicine 1992;327:1350-5.
10. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999;282:1523-9.
11. Must A, Strauss RS. Risks and consequences of childhood and adolescent obesity. International Journal of Obesity and Related Metabolic Disorders 1999;23 Suppl 2:S2-11.
12. Nieto FJ, Szklo M, Comstock GW. Childhood weight and growth rate as predictors of adult mortality. American Journal of Epidemiology 1992; 136:201-13.
13. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA 2003;289:187-93.
14. Olshansky SJ, Passaro DJ, Hershow RC, et al. A potential decline in life expectancy in the United States in the 21st century. N EngL J Med 2005;352:1138-45.
15. Goran MI. Metabolic precursors and effects of obesity in children: a decade of progress, 1990-1999. Am J Clin Nutr 200 1;73:158-71.
16. Mallare JT, Karabell AH, Velasquez-Mieyer P, Stender SRS, Christensen ML. Current and future treatment of metabolic syndrome and Type 2 diabetes in children and adolescents. (From Research to Practice/ Diabetes and Youth). Diabetes Spectrum 2005; 18:220-229.
17. Barlow S. E. DWH. Obesity Evaluation and Treatment: Expert Committee Recommendations. Pediatrics 1998;102:E29.
18. American Diabetes Association. Diabetes facts. Retrieved from the World Wide Web July 31, 2000 2000; Http://www.diabetes.org/adai/info/ diabfact.htm.
19. Burghen GA CM, Krichevsky S, West B, Rose SR, Velasquez-Mieyer P, Danish R, Broome DC, Lustig RH. Type 2 Diabetes Mellitus epidemic in African-American Children. Pediatr Res 2000;47: (Abstract).
20. Burghen GA CM, Krichevsky S, West B, Rose SR, Velasquez-Mieyer P, Danish R, Broome DC, Lustig RH. Characteristics of Type 1 and Type 2 New-Onset Diabetes in Children. Pediatr Res 2000;47: (Abstract).
21. Goran MI, Ball GD, Cruz ML. Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab 2003;88:1417-27.
22. Ten S, Maclaren N. Insulin resistance syndrome in children. J Clin Endocrinol Metab 2004;89:2526-39.
23. Velasquez-Mieyer PA, Cowan PA, Cuervo R, et al. Does obesity matter in children with type 2 diabetes? Diabetes 2002;51:A362.
24. Arslanian SA. Type 2 diabetes in children: clinical aspects and risk factors. Hormone Research. 2002;57 Suppl 1: 19-28.
25. Bloch CA, Clemons P, Sperling MA. Puberty decreases insulin sensitivity. Journal of Pediatrics 1987;110:481-7.
26. Anonymous. Type 2 diabetes in children and adolescents. American Diabetes Association. Pediatrics. 2000;105:671-80.
27. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2007;30:S42-47S.
28. Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. New England Journal of Medicine 2002;346:802-10.
29. Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care. 2000;23:295-301.
30. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-70.
31. Conwell LS, Trost SG, Brown WJ, Batch JA. Indexes of Insulin Resistance and Secretion in Obese Children and Adolescents: A validation study. Diabetes Care 2004; 27:314-319.
32. Uwaifo GI, Parikh SJ, Keil M, Elberg J, Chin J, Yanovski JA. Comparison of insulin sensitivity, clearance, and secretion estimates using euglycemic and hyperglycemic clamps in children. J Clin Endocrinol Metab 2002;87:2899-905.
33. Mather KJ, Hunt AE, Steinberg HO, et al. Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab 2001;86:5457-64.
34. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-10.
35. Yokoyama H, Emoto M, Fujiwara S, et al. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients. Diabetes Care. 2003;26:2426-32.
36. Sluiter WJ, Erkelens DW, Terpstra P, Reitsma WD, Doorenbos H. Glucose tolerance and insulin release, a mathematical approach. II. Approximation of the peripheral insulin resistance after oral glucose loading. Diabetes 1976;25:245-9.
37. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
38. Uwaifo GI, Fallon EM, Chin J, Elberg J, Parikh SJ, Yanovski JA. Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children. Diabetes Care. 2002;25:2081-7.
39. Gungor N, Saad R, Janosky J, Arslanian S. Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr 2004;144:47-55.
40. Velasquez-Mieyer PA, P.A. C, Perez-Faustillini S, Markee J, Burghen GA. Predicting impaired glucose tolerance in severely obese adolescents. Proceedings of the International Congress of Endocrinology 2004:1433-1437.
41. Velasquez-Mieyer PA, Perez-Faustillini S, Cowan PA. Identifying children at risk for obesity, type 2 diabetes, and cardiovascular disease. Diabetes Spectrum 2005;18:213-220.
42. Cowan PA, Velasquez PA, Neira CP, Villegas-Barreto C, Tylavsky F. Relative body mass index correlates with DXA measures of body fat in children of varying ages and adiposity. Obesity Research 2006.
43. Lustig RH, Rose SR, Burghen GA, et al. Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. Journal of Pediatrics 1099; 135:162-8.
44. Rosenbloom AL, Wheeler L, Bianchi R, Chin FT, Tiwary CM, Grgic A. Age-adjusted analysis of insulin responses during normal and abnormal glucose tolerance tests in children and adolescents. Diabetes 1975;24(9):820-8.
45. Velasquez-Mieyer PA, Cowan PA, Christensen M, Lunar L, Markwell S, Burghen GA. Can OGTT-derived indices uncover an overweight threshold for deterioration in adolescent glucose metabolism? Diabetologia 2003;46:A26.
46. Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2006;29:1130-9.
47. Christensen ML, Rashed SM, Sinclair J, Cowan PA, PA. V-M, Burghen GA. Type 2 diabetes mellitus in children and adolescents: The new challenge. The Journal of Pediatric Pharmacology and Therapeutics 2004;9:15-26.
48. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999;22:345-54.
49. ADA. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
50. Arslanian SA, Lewy VD, Danadian K. Glucose intolerance in obese adolescents with polycystic, ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease. Journal of Clinical Endocrinology and Metabolism 2001;86:66-71.
51. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. [see comment]. J Clin Endocrinol Metab 1999;84(1):165-9.
52. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50,
53. Greenbaum CJ, Cuthbertson D, Krischer JP, Disease Prevention Trial of Type IDSG. Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria. Diabetes 2001;50(2):470-6.
54. Fagot-Campagna A, Saaddine JB, Flegal KM, Beckles GL. Diabetes, impaired fasting glucose, and elevated HbA1c in U.S. adolescents: the Third National Health and Nutrition Examination Survey. Diabetes Care 2001;24:834-7.
55. Yeckel CW, Weiss R, Dziura J, et al. Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. Journal of Clinical Edocrinology and Metabolism 2004;89:1096-101.
56. Gungor N, Arslanian S. Pathophysiology of Type 2 Diabetes Mellitus in Children and Adolescents. Treat Endocrinol 2002;1:359-71.
57. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Charles MA, Bennett PH. A two-step model for development of non-insulin-dependent diabetes. Am J Med 1991;90(2):229-35.
58. Jiang X, Srinivasan SR, Berenson GS. Relation of obesity to insulin secretion and clearance in adolescents: the Bogalusa Heart Study. Int J Obes Relat Metab Disord 1996;20(10):951-6.
59. Polonsky KS. Dynamics of insulin secretion in obesity and diabetes. Int J Obes Relat Metab Disord 2000;24 Suppl 2:S29-31.
60. Huang TT, Johnson MS, Goran MI. Development of a prediction equation for insulin sensitivity from anthropometry and fasting insulin in prepubertal and early pubertal children. Diabetes Care. 2002;25(7):1203-10.
61. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care. 1999;22(2):345-54.
62. Wannamethee SG, Shaper AG. Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care. 1999;22(8):1266-72.
63. Green C, Hoppa RD, Young TK, Blanchard JF. Geographic analysis of diabetes prevalence in an urban area. Soc Sci Med 2003;57(3):551-60.
64. Daniels S. Pharmacological treatment of obesity in paediatric patients. Paediatric Drugs. 2001;3:405-10.
65. Eriksson J, Lindstrom J, Valle T, et al. Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia. 1999;42(7):793-801.
66. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine 2002;346:393-403.
67. Sinha. R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802-10.
68. Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 2005;28:902-9.
69. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab 2004;99:108-13.
70. Bacha F, Saad R, Gungor N, Arslanian SA. Are obesity-related metabolic risk factors modulated by the degree of insulin resistance in adolescents? Diabetes Care 2006;29:1599-604.
71. Ku CY, Gower BA, Hunter GR, Goran MI. Racial differences in insulin secretion and sensitivity in prepubertal children: role of physical fitness and physical activity. Obesity Research 2000;8:506-15.
72. Cowan PA, Velasquez-Mieyer PA, Markee J, Christensen M, Perez-Faustinelli S, Burghen GA. Severity of overweight affects cardiovascular risk in African-American youth with and without type 2 diabetes mellitus. Obesity Research 2003;11:A53.
73. Cowan PA, Velasquez-Mieyer PA, Markee J, Weakly C, Christensen M, G.A. B. Impact of overweight on cardiovascular risk factors of African-American children. Diabetologia 2003;46:A370.
74. Velasquez-Mieyer PA, Cowan PA, Alpert BS, et al. Fitness capacity is the major predictor of the number of cardiovascular risk factors in obese adolescents Atherosclerosis 2006;7:381.
75. Skrha J, Haas T, Sindelka G, et al. Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders. J Clin Endocrinol Metab 2004;89:135-41.
76. Chen H, Sullivan G, Quon MJ. Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model. Diabetes 2005;54:1914-25.
77. Hanley AJ, Williams K, Gonzalez C, et al. Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. Diabetes 2003;52:463-9.
78. Uwaifo GI, Fallon EM, Chin J, Elberg J, Parikh SJ, Yanovski JA. Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children. Diabetes Care 2002;25:2081-7.
79. Hanson RL, Pratley RE, Bogardus C, et al. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 2000;151:190-8.